Certainly, there are other diseases that stand to benefit from predictive modeling. An additional point to remember is that some diseases that are particularly burdensome to society (for example, asthma and chronic kidney disease) are of particular interest to administrators and are being very actively funded and studied by both public agencies at the national, state, and local levels, as well as by private corporations.